AdaptHealth Corp. (AHCO) Misses Q2 EPS by 10c

AdaptHealth Corp. (NASDAQ: AHCO) reported Q2 EPS of $0.12, $0.10 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $617 million versus the consensus estimate of $575.53 million.

GUIDANCE:

AdaptHealth Corp. sees FY2021 revenue of $2.38-2.48 billion, versus the consensus of $2.3 billion.

For earnings history and earnings-related data on AdaptHealth Corp. (AHCO) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Customers Bancorp (CUBI) Tops Q1 EPS by 3c
• Arca Biopharma (ABIO) Reports Q1 Loss of $0.14